Global Retrovirus Testing Market is Likely to Grow at a CAGR Value of 16.5% By 2028

The global retrovirus testing market size was worth USD 182.4 million in 2021 and is estimated to grow to USD 456.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.5 percent during the forecast period. The report analyzes the retrovirus testing market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the retrovirus testing market.

Retroviruses are viruses whose genetic material is RNA. It contains reverse transcriptase, an enzyme that transforms RNA to DNA after contaminating a cell. Then, for replication, it fuses its DNA with the host DNA. Retroviruses are viruses in the Retroviridae family. One of the widespread retroviruses known to afflict humans with the disease is the human immunodeficiency virus (HIV). Other types of retroviruses include HIV 1, HIV 2, HTLV-1, HTLV-2, and the human T-cell lymphotropic virus type-1. Retrovirus must be detected early and treated appropriately to treat this potentially fatal infection as it is the causative agent for many life-threatening diseases, including HIV-AIDS. Retrovirus screening can be done using a variety of diagnostic testing. The increased use of retrovirus testing generates substantial revenues in the global retrovirus testing market owing to increased demand in diagnostic laboratories and hospitals. On the other hand, the retrovirus testing industry is generating profit due to the rising incidence of HIV-infectious diseases, STDs, and rising research expenditure globally.

Some of the key factors expected to propel the expansion of the global retrovirus testing market are the increasing capacity of retrovirus tests that can provide instant results, enabling immediate treatment decisions, the high accessibility of high-end retrovirus diagnostic tools, assays, and kits, as well as being an efficient screening method for retrovirus testing. The development of quick and technologically sophisticated methods for detecting retroviral infections, rising public awareness of diagnostic tests, and rising R&D spending on retrovirus screening further contribute to the market's expansion for retrovirus testing. However, the lack of trained personnel to perform sensitive assays related to retrovirus testing and the high cost of assay methods & diagnostic kits are some factors limiting the growth of the retrovirus testing market.

The global retrovirus testing market is segregated based on test type, technique type, sample type, end-user, and region. Based on test type, the market is divided into infectivity assay, product-enhanced reverse transcriptase (PERT) assay, co-cultivation assay, transmission electron microscopy, radio-immune assay, western blot analysis, immunofluorescence, and serological tests. Among these, the infectivity assays segment led the market in 2021 and is expected to maintain its dominance throughout the forecast period. Based on technique type, the market is classified into high-throughput screening, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR). In 2021, the High-throughput screening methods and PCR-based amplification category dominated the global market. The market is classified into blood, serum, body fluids, and cells based on sample type. In 2021, the blood segment dominated the global market. Based on end-user, the market is classified into hospitals, clinics, and diagnostic laboratories & centers. The diagnostic laboratories & centers category dominated the market in 2021.

The global retrovirus testing market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Due to increased awareness about retrovirus diagnosis, well-established healthcare infrastructure, and an increase in investments in activities of research & development, North America is anticipated to have a dominating position in the worldwide market for retrovirus testing in 2021. According to HIV.gov statistics published in June 2021, nearly 2 million individuals in the United States have HIV, resulting in 34,800 HIV infectious diseases in 2019 at a rate of 12.6% (per 100,000 people). This suggests that the prevalence of HIV in the nation is high, which will increase demand for its diagnosing products and further propel the regional market. Additionally, between 2022 and 2028, the market in the Asia Pacific is anticipated to develop at the greatest CAGR. The growing medical research in nations like China, Japan, India, and others, along with increased research on STDs, contributes to the regional market's expansion. Additionally, the number of patients in developing nations rises due to carelessness during blood transfusions and unprotected sex with an HIV-positive person. In Asia-Pacific, 5.9 million people are living with HIV, and only 54% receive treatment.

Key players in the global retrovirus testing market include BGI Genomics, Abbott Diagnostics, Alere Inc, Hybribio Biotech, Roche Diagnostics Ltd, Tellgen Corporation, DiaSorin S.p.A., Dian Diagnostics, bioMerieux SA, Becton, Dickinson & Company, Xilong Scientific.

Recent Development:

• November 2021: Roche Diagnostics introduced the Cobas 5800 system.
• May 2020: OraSure Technologies Inc. purchased UrSure Inc., a well-known laboratory testing company. This acquisition has expanded the company's HIV diagnostic product offerings.
• December 2020: Atomo Diagnostic has signed a distribution deal with PrEP Health Pty Ltd for HIV self-testing kits. This has expanded the customer base and strengthened the HIV diagnostics product portfolio.

Browse the full “Retrovirus Testing Market By Test Type (Infectivity Assay, Product-Enhanced Reverse Transcriptase (PERT) Assay, Co-Cultivation Assay, Transmission Electron Microscopy, Radio-Immune Assay, Western Blot Analysis, Immunofluorescence, Serological Tests), By Technique Type (High-Throughput Screening, Enzyme-Linked Immuno-Sorbent Assay (ELISA), Polymerase Chain Reaction (PCR)), By Sample Type (Blood, Serum, Body Fluids, Cells), By End-User (Hospitals, Clinics, Diagnostic Laboratories & Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/retrovirus-testing-market

Global Retrovirus Testing Market is segmented as follows:

By Test Type

• Infectivity Assay
• Product-Enhanced Reverse Transcriptase (PERT) Assay
• Co-Cultivation Assay
• Transmission Electron Microscopy
• Radio-Immune Assay
• Western Blot Analysis
• Immunofluorescence
• Serological Tests

By Technique Type

• High-Throughput Screening
• Enzyme Linked Immuno-Sorbent Assay (ELISA)
• Polymerase Chain Reaction (PCR)

By Sample Type

• Blood
• Serum
• Body Fluids
• Cells

By End User

• Hospitals
• Clinics
• Diagnostic Laboratories & Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com